Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Yurong Peng; Zhuo Li; Yucheng Fu; Yue Pan; Yue Zeng; Junqi Liu; Chaoyue Xiao; Yingzhe Zhang; Yahui Su; Guoqing Li; Fang Wu

doi:10.3389/fonc.2023.1163376

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Front Oncol. 2023 Mar 29:13:1163376. doi: 10.3389/fonc.2023.1163376. eCollection 2023.

Authors

Yurong Peng¹, Zhuo Li², Yucheng Fu¹, Yue Pan¹, Yue Zeng¹, Junqi Liu¹, Chaoyue Xiao¹, Yingzhe Zhang¹, Yahui Su³, Guoqing Li³, Fang Wu¹

Affiliations

¹ Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
² The Ophthalmologic Center of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
³ XiangYa School of Public Health, Central South University, Changsha, Hunan, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1011810.].

Keywords: NSCLC; adjuvant therapy; biomarkers; immunotherapy; lung cancer; neoadjuvant immune monotherapy; neoadjuvant therapies; perioperative period perioperative immunotherapy.

Publication types

Published Erratum